Getting a Supplier to Pay Its Share After the Notice Deadline Passed

The situation

What frightened Maricel and Jomar was not the recall notice itself, or even the cost of pulling product off shelves. It was the phone call they were dreading from the buyer at a national pet retail chain that had carried their joint-care supplement for three years, the call where the buyer would say the listing was gone for good. A recall handled badly does not just cost money. It costs the relationships a small company spends years building with retailers and veterinary clinics who have to trust that what they put on their shelves is safe, and those relationships do not come back just because the underlying problem gets fixed.

Maricel, a veterinarian, and Jomar, a former police sergeant, had built the company together over six years into a business generating between five and twenty million dollars in annual revenue, selling supplements through veterinary clinics and specialty retailers across the region. A silent investor, Tariq, had put in early capital and stayed out of daily operations, checking in mainly through quarterly updates.

The trouble started when a customer complaint led Maricel to test a recent production batch and find contamination traced to a raw ingredient from their longtime supplier. The company moved immediately, pulling stock from retailers and issuing a recall notice to the clinics and stores carrying the affected batch. That work consumed every waking hour for weeks. Retailer calls, replacement stock, customer communications, testing to confirm the scope of the contamination, and coordinating with the supplier all had to happen at once, with a small team and no recall playbook to follow.

By the time the immediate crisis was under control and Maricel and Jomar turned to the question of who should pay for it, six weeks had passed. Their supply agreement with the ingredient supplier required written notice of any quality claim within a set window after discovering the defect, and that window had already closed before anyone thought to check the contract for it.

The complication

The missed notice deadline was the first thing we found once retained, and it was a genuine problem, not a technicality to wave away. Supply agreements typically use a notice requirement precisely so a supplier is not blindsided months later by a claim it cannot investigate while the facts are fresh. Missing that window gives the supplier a straightforward argument to deny the claim outright, regardless of whether the contamination was actually its fault.

We reviewed the agreement closely and confirmed the notice clause was real and enforceable on its face. There was no ambiguity to exploit, and no argument that the deadline had somehow been met. What mattered instead was what leverage still existed despite the missed deadline, because a contractual notice requirement affects a formal legal claim, it does not erase the underlying facts or the ongoing business relationship between the two companies.

Two things worked in the company's favour. First, the supplier's own internal testing records, obtained through the recall investigation, showed contamination in the same ingredient lot before it was even shipped, meaning the supplier had documentation of its own quality failure independent of anything the company asserted. Second, the two companies had a five-year supply relationship worth continuing for both sides, and the supplier had commercial reasons to resolve the dispute without a public fight that would raise questions about its own quality controls with other customers.

The complication, then, was not whether the supplier bore real responsibility. The evidence on that point was strong. It was whether a missed contractual deadline would let the supplier avoid that responsibility on a technicality regardless of the underlying facts, and whether a negotiated resolution could be reached before that question ever had to be tested formally.

There was also a harder question underneath the enforceability issue. Even if the supplier chose to overlook the missed deadline informally, a verbal or unwritten accommodation would have left the company relying on the supplier's goodwill rather than on an enforceable term, exactly the position a written notice clause exists to prevent in the first place. Anything short of a documented settlement risked the same argument resurfacing later, on a future claim, once the immediate relationship pressure that favoured cooperation had faded.

What we did

1. Confirmed the scope and enforceability of the missed notice clause first, rather than assuming it could be argued around on some technicality, so the negotiating strategy was built on an accurate picture of the company's actual legal position rather than wishful thinking. Confirming the weakness honestly, before doing anything else, meant the company never opened a conversation with the supplier from a position it could not actually defend if the supplier pushed back on the timing.
2. Assembled the supplier's own testing records into a clear timeline, showing contamination present before shipment, which gave the company independent evidence of the supplier's fault that did not depend on the company's own notice having been timely. Building this timeline first, before any conversation with the supplier began, meant the company could lead with documented fact rather than accusation, which is a materially stronger position when a contract's own notice deadline has already been missed.
3. Calculated the full recall cost in detail, including replaced stock, testing, retailer credits, and lost shelf placement, so any negotiation started from a documented figure rather than a rough estimate the supplier could dispute line by line. A vague cost estimate invites a supplier to negotiate down from uncertainty; an itemized figure, backed by invoices and retailer correspondence, forces the conversation onto the actual dollars at stake rather than an argument about what the real number even is.
4. Opened settlement discussions rather than filing a claim, framing the missed notice deadline honestly while presenting the contamination evidence, since a formal claim would have invited the supplier to lead with the deadline defence instead of engaging with the substance of what its own records showed. Naming the weakness upfront, rather than hoping the supplier would not notice it, took away the supplier's easiest opening move and forced the conversation onto the facts that actually favoured the company.
5. Emphasized the ongoing commercial relationship in every conversation, making clear the company wanted a resolution that let the five-year relationship continue rather than a fight that would end it, which gave the supplier a path to resolve the matter without treating it as adversarial litigation. A supplier facing a purely legal threat has every incentive to fight; a supplier being offered a way to keep a valued customer while addressing a real quality failure has a business reason to settle instead.
6. Negotiated a cost-sharing settlement in stages, starting with the supplier's clearest area of exposure, the ingredient cost and immediate testing expenses, before addressing the larger and harder-to-quantify retail relationship costs. Securing agreement on the undisputed items first built momentum and established the supplier's willingness to pay before the conversation moved to the costs it had more room to argue about, rather than trying to settle every category of cost in one difficult conversation.
7. Documented the settlement with updated supply terms going forward, including a shorter, more prominent notice requirement and a defined quality testing protocol, so the same gap could not recur on the next issue. Fixing only the immediate dispute without addressing why the deadline had been missed in the first place would have left the company exposed to the identical problem the next time a quality issue arose, so the settlement deliberately closed that gap for the future.

The outcome

The supplier agreed to fund a substantial majority of the recall costs, including the ingredient replacement, product testing, and a significant portion of the retailer credits the company had extended to keep its shelf space. The settlement was reached without either company filing a claim, and the supply relationship continued on updated terms.

The final split covered the ingredient replacement and testing expenses in full, plus most of the retailer credits, leaving Maricel and Jomar's company responsible for a smaller remaining share itself. That division came directly out of the staged approach: the undisputed costs settled quickly and set the tone, while the harder-to-quantify retail relationship costs became the last and most negotiated part of the conversation. Maricel and Jomar chose to accept covering a portion of those costs themselves rather than pushing for full recovery, judging that preserving goodwill with a supplier they intended to keep working with mattered more than extracting the last few percentage points.

The missed notice deadline never had to be tested, because the supplier's own testing records made its underlying responsibility difficult to dispute, and its interest in preserving the relationship outweighed the value of relying on a technical defence. That said, the outcome depended on evidence the company was fortunate to have, and the missed deadline remained real exposure the entire time the negotiation was underway. A supplier less concerned with the relationship, or without its own documentation working against it, could have taken a harder line.

The retail relationships Maricel and Jomar feared losing held. The national chain kept the product listed, crediting the company's fast and transparent handling of the recall as much as the outcome with the supplier. The updated supply agreement now gives the company a shorter, clearly flagged notice window and a defined testing protocol, closing the gap that nearly cost them the claim the first time.

What you can learn from this